Preferred Label : tegafur;
MeSH definition : Congener of FLUOROURACIL with comparable antineoplastic action. It has been suggested
especially for the treatment of breast neoplasms.;
MeSH synonym : 1-(tetrahydro-2-furanyl)-5-fluorouracil; n1-(2'-tetrahydrofuryl)-5-fluorouracil; 1-(2-tetrahydrofuryl)-5-fluorouracil; 5-fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione;
CISMeF synonym : 5-fluoro-1-(tetrahydro-2-furyl)uracil; prasfarma brand of tegafur; almirall brand of tegafur; Bristol-Myers squibb brand of tegafur; bristol myers squibb brand of tegafur;
MeSH hyponym : sunfural S; futraful; utefos; FT-207; uftoral; florafur; ftorafur; FT 207; FT207; Fluorofur;
MeSH CAS label : 2,4(1H,3H)-Pyrimidinedione, 5-fluoro-1-(tetrahydro-2-furanyl)-;
MeSH Related Number : 17902-23-7 (Tegafur);
Registry Number MeSH : 17902-23-7;
Wikipedia link : https://en.wikipedia.org/wiki/Tegafur;
Codes EINECS : 241-846-2;
Is substance : O;
UNII : 1548R74NSZ;
InChIKey : WFWLQNSHRPWKFK-UHFFFAOYSA-N;
Origin ID : D005641;
UMLS CUI : C0016778;
ATC code(s)
ATC code(s)
Allowable qualifiers
CISMeF manual mappings
Currated CISMeF NLP mapping
Pharmacological action(s)
Record concept(s)
Related MeSH Supplementary Concept(s)
- 3-FT [MeSH Supplementary Concept]
- FD 1 [MeSH Supplementary Concept]
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
Congener of FLUOROURACIL with comparable antineoplastic action. It has been suggested
especially for the treatment of breast neoplasms.
https://www.has-sante.fr/jcms/p_3428419/fr/teysuno-gimeracil/tegafur/oteracil-cancer-colorectal
2023
false
false
false
France
tegafur-gimeracil-oteracil
treatment outcome
insurance, health, reimbursement
adult
antineoplastic combined chemotherapy protocols
tegafur, combinations
neoplasm metastasis
antineoplastic agents
drug combinations
tegafur
gimeracil
oxonic acid
evaluation of the transparency committee
colorectal neoplasms
---
https://ansm.sante.fr/informations-de-securite/Medicaments-a-base-de-5-fluorouracile-voie-parenterale-capecitabine-tegafur-et-flucytosine-recommandations-europeennes-concernant-la-recherche-du-deficit-en-dihydropyrimidine-deshydrogenase-DPD
2020
false
false
false
France
French
guidelines for drug use
Capecitabine
tegafur
flucytosine
fluorouracil
dihydropyrimidine dehydrogenase deficiency
Drug-Related side effects and adverse reactions
mass screening
---
https://www.ansm.sante.fr/actualites/5-fu-et-deficit-en-dpd-lema-poursuit-le-travail-initie-en-france
2019
false
false
false
France
French
drug information
fluorouracil
genetic testing
Capecitabine
tegafur
flucytosine
antimetabolites
dihydropyrimidine dehydrogenase deficiency
france
europe
antimetabolites, antineoplastic
fluorouracil
Capecitabine
tegafur
flucytosine
antimetabolites
antimetabolites, antineoplastic
---
http://www.has-sante.fr/portail/jcms/c_1329540/teysuno
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-10/teysuno__03102012_avis_ct12048.pdf
2012
false
France
French
tegafur-gimeracil-oteracil
tegafur-gimeracil-oteracil
drug combinations
administration, oral
gimeracil
gimeracil
adult
stomach neoplasms
antineoplastic combined chemotherapy protocols
tegafur
tegafur
oxonic acid
oxonic acid
tegafur, combinations
antineoplastic agents
antineoplastic agents
insurance, health, reimbursement
evaluation of the transparency committee
treatment outcome
randomized controlled trials as topic
survival analysis
pyridines
pyridines
drug combinations
drug combinations
---
https://www.ema.europa.eu/medicines/human/EPAR/Teysuno
2012
false
United Kingdom
French
English
tegafur-gimeracil-oteracil
tegafur-gimeracil-oteracil
syndication feed
tegafur
gimeracil
oxonic acid
drug combinations
gimeracil
tegafur
oxonic acid
drug approval
treatment outcome
pyridines
pyridines
tegafur, combinations
administration, oral
adult
antineoplastic agents
antineoplastic agents
stomach neoplasms
antineoplastic combined chemotherapy protocols
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
pyridines
summary of product characteristics
package leaflet
drug evaluation
drug combinations
drug combinations
---
http://www.has-sante.fr/portail/jcms/c_1244174/uft
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-05/uft_11042012_avis_ct10161.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_400954
http://www.has-sante.fr/portail/display.jsp?id=c_399171
2012
France
French
evaluation of the transparency committee
tegafur, combinations
drug combinations
administration, oral
insurance, health, reimbursement
UFT(R) drug
tegafur
uracil
antineoplastic agents
neoplasm metastasis
colorectal neoplasms
antineoplastic combined chemotherapy protocols
leucovorin
---
http://www.has-sante.fr/portail/display.jsp?id=c_601786
http://www.has-sante.fr/portail/display.jsp?id=c_601796
2007
France
French
Contraindications, Procedure
uracil
drug combinations
colorectal neoplasms
neoplasm metastasis
drug therapy, combination
capsules
administration, oral
antimetabolites, antineoplastic
drug prescriptions
uracil
tegafur
antimetabolites, antineoplastic
uracil
tegafur
antimetabolites, antineoplastic
pregnancy
drug interactions
uracil
tegafur
antimetabolites, antineoplastic
leucovorin
tegafur
continuity of patient care
adult
tegafur, combinations
UFT(R) drug
guidelines for drug use
Contraindications, Drug
---